Selected publications
-
Pharmacokinetics of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumors: The role of alpha-1-acid glycoprotein binding.
Clinical Cancer Research.
2011
Academic Article
GET IT
Times cited: 78 -
Phase I trial of irinotecan, infusional 5-fluorouracil, and leucovorin (FOLFIRI) with erlotinib (OSI-774): Early termination due to increased toxicities.
Clinical Cancer Research.
2004
Academic Article
GET IT
Times cited: 82